Delivery Order SPE2DB25D3020-SPE2DB25FWJLF
Award Date
7/10/25
Potential Completion Date
7/11/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Bupropion HCL XL 300 mg tablets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $61,602.41 and an ultimate completion date of December 22, 2023. It was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This is a delivery order contract with a firm fixed-price pricing type. The contract does not have a set-aside designation, indicating it was awarded through full and open...
The federal contract award is for the delivery of BUPROPION HCL XL 150 MG TABLET 500S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $3,941.46 and an ultimate completion date of April 30, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of 500 units of Bupropion HCL XL 300 mg tablets, a prescription medication, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $1,550.78. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,809.95 firm fixed-price delivery order contract is for the supply of BUPROPION HCL XL 300 MG TABLET 500S, a prescription medication. The contract has an ultimate completion date of February 20, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of bupropion HCL XL 300 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $20,759.83, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Bupropion HCL XL 300 mg tablets to the Defense Logistics Agency (DLA). The award, valued at $28,378.07, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on a Firm Fixed Price basis. The contract has an ultimate completion date of February 6, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Both companies are registered as for-profit...
The federal contract award, with ID SPE2DX15D3404|SPE2DX24F0ZYJ, is for the delivery of 4,563,586,968 units of Bupropion HCL XL 150 mg tablets in 500-count bottles. The contract, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a firm fixed-price delivery order with a ceiling value of $23,937.54. The contract has an ultimate completion date of February 8, 2024 and was awarded on February 7, 2024. The contracting agency is the Defense Logistics Agency (DLA) Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4,564,543,508 units of Bupropion HCL XL 300 mg tablets. The contract has a ceiling value of $13,933.62 and is a firm fixed-price delivery order that will run through May 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of 4563955517 - Bupropion HCl XL 300 mg Tablets in 500-count bottles. The contract is a firm fixed price delivery order with a ceiling value of $14,784.85 and a period of performance through March 14, 2024. No set-aside designation was used for this...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,876.60, is for the delivery of Bupropion HCL XL 300 mg tablets and is a firm fixed-price delivery order with a completion date of May 1, 2024. The contract is not designated as a set-aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...